相似文献
1
MiRNA inhibition in tissue engineering and regenerative medicine.
Adv Drug Deliv Rev. 2015 Jul 1;88:123-37. doi: 10.1016/j.addr.2014.12.006. Epub 2014 Dec 29.
2
MicroRNA delivery for regenerative medicine.
Adv Drug Deliv Rev. 2015 Jul 1;88:108-22. doi: 10.1016/j.addr.2015.05.014. Epub 2015 May 27.
3
MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine.
Physiol Genomics. 2011 May 1;43(10):517-20. doi: 10.1152/physiolgenomics.00037.2011. Epub 2011 Apr 5.
4
Tissue engineering and microRNAs: future perspectives in regenerative medicine.
Expert Opin Biol Ther. 2015;15(11):1601-22. doi: 10.1517/14712598.2015.1071349. Epub 2015 Jul 22.
5
Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine.
Curr Stem Cell Res Ther. 2017;12(3):233-246. doi: 10.2174/1574888X11666160905092513.
6
Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue.
Regen Med. 2014 Jan;9(1):89-100. doi: 10.2217/rme.13.81.
7
Skin regeneration: the complexities of translation into clinical practise.
Int J Biochem Cell Biol. 2014 Nov;56:133-40. doi: 10.1016/j.biocel.2014.10.025. Epub 2014 Oct 29.
8
Preparation and evaluation of natural scaffold materials for kidney regenerative applications.
Methods Mol Biol. 2013;1001:133-43. doi: 10.1007/978-1-62703-363-3_11.
9
Recent insights on applications of pullulan in tissue engineering.
Carbohydr Polym. 2016 Nov 20;153:455-462. doi: 10.1016/j.carbpol.2016.07.118. Epub 2016 Aug 1.
10
Potential of endogenous regenerative technology for in situ regenerative medicine.
Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):741-52. doi: 10.1016/j.addr.2010.01.001. Epub 2010 Jan 25.
引用本文的文献
1
Chemical Modifications in Nucleic Acid Therapeutics.
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
The Role of MicroRNAs in Liver Functioning: from Biogenesis to Therapeutic Approaches (Review).
Sovrem Tekhnologii Med. 2023;15(5):54-79. doi: 10.17691/stm2023.15.5.06. Epub 2023 Oct 30.
3
Advances in human umbilical cord mesenchymal stem cells-derived extracellular vesicles and biomaterial assemblies for endometrial injury treatment.
World J Stem Cells. 2025 Jan 26;17(1):97905. doi: 10.4252/wjsc.v17.i1.97905.
4
Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine.
Front Bioeng Biotechnol. 2024 Oct 16;12:1484151. doi: 10.3389/fbioe.2024.1484151. eCollection 2024.
5
Injectable hydrogel encapsulating siMMP13 with anti-ROS and anti-apoptotic functions for osteoarthritis treatment.
J Nanobiotechnology. 2024 Aug 2;22(1):466. doi: 10.1186/s12951-024-02740-w.
6
Deciphering Key microRNA Regulated Pathways in Tissue-Engineered Blood Vessels: Implications for Vascular Scaffold Production.
Int J Mol Sci. 2024 Jun 20;25(12):6762. doi: 10.3390/ijms25126762.
7
RNA Technology to Regenerate and Repair Alveolar Bone Defects.
J Dent Res. 2024 Jun;103(6):622-630. doi: 10.1177/00220345241242047. Epub 2024 May 7.
8
Decoding the secrets of longevity: unraveling nutraceutical and miRNA-Mediated aging pathways and therapeutic strategies.
Front Aging. 2024 Mar 28;5:1373741. doi: 10.3389/fragi.2024.1373741. eCollection 2024.
9
Reciprocal communication between FAPs and muscle cells via distinct extracellular vesicle miRNAs in muscle regeneration.
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2316544121. doi: 10.1073/pnas.2316544121. Epub 2024 Mar 5.
10
Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers.
Mol Ther Nucleic Acids. 2023 Aug 22;33:941-959. doi: 10.1016/j.omtn.2023.08.023. eCollection 2023 Sep 12.
本文引用的文献
1
Antagomir-92a impregnated gelatin hydrogel microsphere sheet enhances cardiac regeneration after myocardial infarction in rats.
Regen Ther. 2016 Jul 16;5:9-16. doi: 10.1016/j.reth.2016.04.002. eCollection 2016 Dec.
2
Enhanced Performance of Plasmid DNA Polyplexes Stabilized by a Combination of Core Hydrophobicity and Surface PEGylation.
J Mater Chem B. 2014 Dec 14;2(46):8154-8164. doi: 10.1039/C4TB00352G.
3
Therapeutic targeting of microRNAs: current status and future challenges.
Nat Rev Drug Discov. 2014 Aug;13(8):622-38. doi: 10.1038/nrd4359. Epub 2014 Jul 11.
4
Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin.
Mol Ther. 2014 Oct;22(10):1839-50. doi: 10.1038/mt.2014.115. Epub 2014 Jun 23.
5
Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects.
Acta Biomater. 2014 Oct;10(10):4390-9. doi: 10.1016/j.actbio.2014.06.015. Epub 2014 Jun 17.
6
In situ synthesis of peptide nucleic acids in porous silicon for drug delivery and biosensing.
Bioconjug Chem. 2014 Jul 16;25(7):1192-7. doi: 10.1021/bc5001092. Epub 2014 Jun 24.
7
Small molecule delivery through nanofibrous scaffolds for musculoskeletal regenerative engineering.
Nanomedicine. 2014 Nov;10(8):1691-9. doi: 10.1016/j.nano.2014.05.013. Epub 2014 Jun 5.
8
Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells.
Adv Drug Deliv Rev. 2015 Jan;81:117-27. doi: 10.1016/j.addr.2014.05.010. Epub 2014 May 22.
9
Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation.
Biomaterials. 2014 Aug;35(24):6278-6286. doi: 10.1016/j.biomaterials.2014.04.048. Epub 2014 May 13.
10
Macro and small over micro: macromolecules and small molecules that regulate microRNAs.
Chembiochem. 2014 May 26;15(8):1071-8. doi: 10.1002/cbic.201402007. Epub 2014 May 2.
Zotero 插件